Topical Dorzolamide for the Treatment of Cystoid Macular Edema in Patients With Retinitis Pigmentosa

American Journal of Ophthalmology

Volumn 141, Issue 5, 2006, Pages 850-858

  Grover, Sandeep ^a   Apushkin, Marsha A ^a   Fishman, Gerald A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DORZOLAMIDE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG RESPONSE; DRUG SAFETY; EYE; EYE DISCOMFORT; FATIGUE; FEMALE; FOLLOW UP; HUMAN; MALAISE; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA FOVEA; RETINA MACULA CYSTOID EDEMA; RETINITIS PIGMENTOSA; TIME SERIES ANALYSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; CARBONIC ANHYDRASE INHIBITORS; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FEMALE; HUMANS; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINITIS PIGMENTOSA; SULFONAMIDES; THIOPHENES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 33646185511     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2005.12.030     Document Type: Article

References (25)

1. Ffytche T.J. Cystoid maculopathy in retinitis pigmentosa. Trans Ophthalmol Soc U K 92 (1972) 265-283
2. Fetkenhour C.L., Chromokos E., Weinstein J., and Shoch D. Cystoid macular edema in retinitis pigmentosa. Trans Am Acad Ophthalmol Otolaryngol 83 (1977) 515-521
3. Fishman G.A., Fishman M., and Maggiano J.M. Macular lesions associated with retinitis pigmentosa. Arch Ophthalmol 95 (1977) 798-803
4. Fishman G.A., Maggiano J.M., and Fishman M. Foveal lesions seen in retinitis pigmentosa. Arch Ophthalmol 95 (1977) 1993-1996
5. Newsome D.A. Retinal fluorescein leakage in retinitis pigmentosa. Am J Ophthalmol 101 (1986) 354-360
6. Hirakawa H., Iijima H., Gohdo T., and Tsukahara S. Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa. Am J Ophthalmol 128 (1999) 185-191
7. Stanga P.E., Downes S.M., Ahuja R.M., et al. Comparison of optical coherence tomography and fluorescein angiography in assessing macular edema in retinal dystrophies. preliminary results. Int Ophthalmol 23 (2001) 321-325
8. Cox S.N., Hay E., and Bird A.C. Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 106 (1988) 1190-1195
9. Fishman G.A., Gilbert L.D., Fiscella R.G., et al. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol 107 (1989) 1445-1452
10. Fishman G.A., Gilbert L.D., Anderson R.J., et al. Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa. Ophthalmology 101 (1994) 687-693
11. Moldow B., Sander B., Larsen M., et al. The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular edema. Graefes Arch Clin Exp Ophthalmol 236 (1998) 881-889
12. Wolfensberger T.J. The role of carbonic anhydrase inhibitors in the management of macular edema. Doc Ophthalmol 97 (1999) 387-397
13. Weiner J.M. Diuretics and other agents employed in the mobilization of edema fluid. In: Gilman A.G., Rall T.W., Nies A.S., and Taylor P. (Eds). The pharmacological basis of therapeutics. 8th ed (1990), MacMillan, New York 716-718
14. Kass M.A., Kolker A.E., Gordon M., et al. Acetazolamide and urolithiasis. Ophthalmology 88 (1981) 261-265
15. Grover S., Fishman G.A., Fiscella R.G., and Adelman A.E. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. Retina 17 (1997) 222-231
16. Berson E.L., Sandberg M.A., Rosner B., et al. Natural course of retinitis pigmentosa over a three-year interval. Am J Ophthalmol 99 (1985) 240-251
17. Grover S., Fishman G.A., Gilbert L.D., and Anderson R.J. Reproducibility of visual acuity measurements in patients with retinitis pigmentosa. Retina 17 (1997) 33-37
18. Massin P., Vicaut E., Haouchine B., et al. Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 119 (2001) 1135-1142
19. Greenstein V.C., Holopigian K., Siderides E., Seiple W., and Carr R.E. The effects of acetazolamide on visual function in retinitis pigmentosa. Invest Ophthalmol Vis Sci 34 (1993) 269-273
20. Koozekanani D., Roberts C., Katz S.E., and Herderick E.E. Intersession repeatability of macular thickness measurements with the Humphrey 2000 OCT. Invest Ophthalmol Vis Sci 41 (2000) 1486-1491
21. Muscat S., Parks S., Kemp E., and Keating D. Repeatability and reproducibility of macular thickness measurements with the Humphrey OCT system. Invest Ophthalmol Vis Sci 43 (2002) 490-495
22. Browning D.J., and Fraser C.M. Intraobserver variability in optical coherence tomography. Am J Ophthalmol 138 (2004) 477-479
23. Goebel W., and Kretzchmar-Gross T. Retinal thickness in diabetic retinopathy-a study using optical coherence tomography. Retina 22 (2002) 759-767
24. Browning D.J. Interobserver variability in optical coherence tomography for macular edema. Am J Ophthalmol 137 (2004) 1116-1117
25. Fishman G.A., Glenn A.M., and Gilbert L.D. Rebound of macular edema with continued use of methazolamide in patients with retinitis pigmentosa. Arch Ophthalmol 111 (1993) 1640-1646